The "new" Abbott Laboratories will specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie will operate as a research-based pharmaceutical manufacturer.
Wednesday, January 2, 2013
AbbVie (ABBV) began trading on the NYSE on Thur 2 Jan 2013
AbbVie (ABBV) is a spin-off of Abbott Laboratories (ABT). The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013.
The "new" Abbott Laboratories will specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie will operate as a research-based pharmaceutical manufacturer.
The "new" Abbott Laboratories will specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie will operate as a research-based pharmaceutical manufacturer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment